FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3010413675> ?p ?o ?g. }

• W3010413675 endingPage "981" @default.
• W3010413675 startingPage "976" @default.
• W3010413675 abstract "Summary Progressive cytopenia is a serious complication among paediatric patients with inherited bone marrow failure syndromes (IBMFS). Androgens have been used to improve blood counts in different bone marrow failure conditions. Little is known about efficacy and toxicity with new androgens (i.e., danazol) in different types of IBMFS. We identified 29 patients from the Canadian Inherited Marrow Failure Registry, who received oxymetholone or danazol. Sixteen (55%) had haematological response including patients with unclassified IBMFS (45%). Danazol showed a better toxicity profile and similar efficacy compared to oxymetholone. Androgens are an effective and safe option to ameliorate bone marrow failure in IBMFS." @default.
• W3010413675 created "2020-03-13" @default.
• W3010413675 creator A5004295731 @default.
• W3010413675 creator A5009626650 @default.
• W3010413675 creator A5014220098 @default.
• W3010413675 creator A5014346242 @default.
• W3010413675 creator A5016099383 @default.
• W3010413675 creator A5016203121 @default.
• W3010413675 creator A5018559508 @default.
• W3010413675 creator A5025885772 @default.
• W3010413675 creator A5036975463 @default.
• W3010413675 creator A5047338069 @default.
• W3010413675 creator A5052569893 @default.
• W3010413675 creator A5061534358 @default.
• W3010413675 creator A5070471288 @default.
• W3010413675 creator A5071722208 @default.
• W3010413675 creator A5073119146 @default.
• W3010413675 creator A5074806944 @default.
• W3010413675 creator A5078017653 @default.
• W3010413675 creator A5078458925 @default.
• W3010413675 creator A5078697252 @default.
• W3010413675 creator A5078894787 @default.
• W3010413675 creator A5086900250 @default.
• W3010413675 creator A5090470087 @default.
• W3010413675 creator A5090925848 @default.
• W3010413675 date "2020-03-03" @default.
• W3010413675 modified "2023-10-18" @default.
• W3010413675 title "Androgen therapy in inherited bone marrow failure syndromes: analysis from the Canadian Inherited Marrow Failure Registry" @default.
• W3010413675 cites W1593508052 @default.
• W3010413675 cites W2003562932 @default.
• W3010413675 cites W2050898703 @default.
• W3010413675 cites W2052662338 @default.
• W3010413675 cites W2053881743 @default.
• W3010413675 cites W2064587482 @default.
• W3010413675 cites W2105862823 @default.
• W3010413675 cites W2125450316 @default.
• W3010413675 cites W2134379604 @default.
• W3010413675 cites W2257333213 @default.
• W3010413675 cites W2341279336 @default.
• W3010413675 cites W2394724717 @default.
• W3010413675 cites W2779449343 @default.
• W3010413675 doi "https://doi.org/10.1111/bjh.16445" @default.
• W3010413675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32128787" @default.
• W3010413675 hasPublicationYear "2020" @default.
• W3010413675 type Work @default.
• W3010413675 sameAs 3010413675 @default.
• W3010413675 citedByCount "7" @default.
• W3010413675 countsByYear W30104136752020 @default.
• W3010413675 countsByYear W30104136752021 @default.
• W3010413675 countsByYear W30104136752022 @default.
• W3010413675 countsByYear W30104136752023 @default.
• W3010413675 crossrefType "journal-article" @default.
• W3010413675 hasAuthorship W3010413675A5004295731 @default.
• W3010413675 hasAuthorship W3010413675A5009626650 @default.
• W3010413675 hasAuthorship W3010413675A5014220098 @default.
• W3010413675 hasAuthorship W3010413675A5014346242 @default.
• W3010413675 hasAuthorship W3010413675A5016099383 @default.
• W3010413675 hasAuthorship W3010413675A5016203121 @default.
• W3010413675 hasAuthorship W3010413675A5018559508 @default.
• W3010413675 hasAuthorship W3010413675A5025885772 @default.
• W3010413675 hasAuthorship W3010413675A5036975463 @default.
• W3010413675 hasAuthorship W3010413675A5047338069 @default.
• W3010413675 hasAuthorship W3010413675A5052569893 @default.
• W3010413675 hasAuthorship W3010413675A5061534358 @default.
• W3010413675 hasAuthorship W3010413675A5070471288 @default.
• W3010413675 hasAuthorship W3010413675A5071722208 @default.
• W3010413675 hasAuthorship W3010413675A5073119146 @default.
• W3010413675 hasAuthorship W3010413675A5074806944 @default.
• W3010413675 hasAuthorship W3010413675A5078017653 @default.
• W3010413675 hasAuthorship W3010413675A5078458925 @default.
• W3010413675 hasAuthorship W3010413675A5078697252 @default.
• W3010413675 hasAuthorship W3010413675A5078894787 @default.
• W3010413675 hasAuthorship W3010413675A5086900250 @default.
• W3010413675 hasAuthorship W3010413675A5090470087 @default.
• W3010413675 hasAuthorship W3010413675A5090925848 @default.
• W3010413675 hasBestOaLocation W30104136751 @default.
• W3010413675 hasConcept C109159458 @default.
• W3010413675 hasConcept C126322002 @default.
• W3010413675 hasConcept C2777416354 @default.
• W3010413675 hasConcept C2779522080 @default.
• W3010413675 hasConcept C2780007613 @default.
• W3010413675 hasConcept C2780366003 @default.
• W3010413675 hasConcept C2780525284 @default.
• W3010413675 hasConcept C28328180 @default.
• W3010413675 hasConcept C2911114841 @default.
• W3010413675 hasConcept C54355233 @default.
• W3010413675 hasConcept C71924100 @default.
• W3010413675 hasConcept C86803240 @default.
• W3010413675 hasConceptScore W3010413675C109159458 @default.
• W3010413675 hasConceptScore W3010413675C126322002 @default.
• W3010413675 hasConceptScore W3010413675C2777416354 @default.
• W3010413675 hasConceptScore W3010413675C2779522080 @default.
• W3010413675 hasConceptScore W3010413675C2780007613 @default.
• W3010413675 hasConceptScore W3010413675C2780366003 @default.
• W3010413675 hasConceptScore W3010413675C2780525284 @default.
• W3010413675 hasConceptScore W3010413675C28328180 @default.
• W3010413675 hasConceptScore W3010413675C2911114841 @default.
• W3010413675 hasConceptScore W3010413675C54355233 @default.

• next